Evaluation of Inner Ear and Brain Structures With Contrast-enhanced MRI in Healthy Subjects (HYDROPS)

Grenoble Alpes University Hospital Center (CHU)

Status and phase: Terminated; Phase 4

Conditions: Meniere Disease

Treatments: Drug: Gadoteric acid

Study type: Interventional

Funder types: Other

Identifiers

NCT02529475

38RC14.428

Details and patient eligibility

About

• This prospective study aims to better characterize inner ear's perilymphatic structures with Magnetic Resonance Imaging using contrast media and delayed injection in healthy subjects
• MR Perfusion Imaging will be assess in both cochlea as well
• Primary auditory brain pathways will be evaluated through MR diffusion imaging

Enrollment: 25 patients

Sex: All

Ages: 40+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Major subjects of over 40 years (mean age of Meniere's disease 40 to 50 years)
• Informed consent signed
• Medical examination performed prior to participation in research
• Patients without history of inner ear disease
• Recipient of a French social security scheme

Exclusion criteria

• Patients minors
• Patients on a legal protection regime type guardianship
• Respiratory pathologies, cardiovascular, renal, diabetes
• Claustrophobia
• Contraindications to exposure to a magnetic field
• Contraindications to injecting Dotarem ®

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

25 participants in 1 patient group

Gadoteric acid

Experimental group

Description:

Gadoteric acid 0.2 mmol/kg

Treatment:

Drug: Gadoteric acid